BVMF/LILY34 (BVMF/LILY34)

Brazil Stock Exchange: BVMF/LILY34 · BRL

R$228

-2.56 (-1.1%)· Recorded snapshot

Market cap	6.1T
Revenue (ttm)	412.7B
Net income (ttm)	138.4B
EPS (ttm)	R$5.31
P/E (trailing)	42.9x
P/E (forward)	33.6x
Dividend	R$0.77 (0.34%)
Volume	111,849
Beta	0.45

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 412.7B
Net income (ttm): 138.4B
EPS (ttm): R$5.31
P/E (trailing): 42.9x
P/E (forward): 33.6x
Market cap: 6.1T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E33.6

P25 n/aP50 n/aP75 n/a

Trailing P/E42.9

P25 n/aP50 n/aP75 n/a

ROE102.3

P25 n/aP50 n/aP75 n/a

ROIC42.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/LILY34 indicators

Market & fundamental data

Available fields

258

Groups with data

Currency

USD

Showing 258 of 258 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-29
Employees	50,000
Employees change	4,000
Employees growth	9.3%
Enterprise value	BRL 6.4T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1876
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRLILYBDR006
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 6.1T
Next earnings date	2026-10-29
Price	BRL 227.84
Price currency	BRL
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bvmf/LILY34
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	52.78x
Average P/E ratio (3Y)	71.41x
Average P/E ratio (5Y)	62.99x
Earnings yield	2.33%
EV/Earnings	45.9x
EV/EBIT	29.99x
EV/EBITDA	28.34x
EV/FCF	67.39x
EV/Sales	14.91x
FCF / EV yield	1.48%
FCF yield	1.54%
Forward P/E	33.58x
Graham number	27.60938
Graham upside	-87.9%
Lynch fair value	BRL 129.21
Lynch upside	-43.38%
P/(FCF - SBC) ratio	67.23x
P/(OCF - SBC) ratio	42.99x
P/B ratio	34.81x
P/E ratio	42.87x
P/FCF ratio	64.83x
P/OCF ratio	41.99x
P/S ratio	14.8x
Price / tangible book value	170.42x
Price/EBITDA ratio	28.28x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	49.72%
EBITDA margin	52.35%
Effective tax rate	20.49%
FCF margin	22.1%
Gross margin	83.4%
Operating margin	49.72%
Pretax margin	42.17%
Profit margin	33.53%
Profit per employee	BRL 2.8M
Profitable quarters	11
Profitable years	8
Revenue per employee	BRL 8.3M
ROA	20.36%
ROA (5Y)	13.51%
ROCE	41.89%
ROE	102.29%
ROE (5Y)	74.21%
ROIC	42.24%
ROIC (5Y)	35.51%
SBC / revenue	0.81%
Tax / revenue	8.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	94.8%
EPS growth (Q)	26.23%
EPS growth (QoQ)	-3.87%
EPS growth 10Y	29.08%
EPS growth 3Y	60.68%
EPS growth 5Y	34.97%
EPS growth quarters	11
EPS growth years	2
FCF growth	272.37%
FCF growth (Q)	458.06%
FCF growth (QoQ)	157.96%
FCF growth 3Y	69.77%
FCF growth 5Y	26.73%
Gross profit growth	50.96%
Gross profit growth (Q)	50.31%
Gross profit growth 3Y	42.51%
Gross profit growth 5Y	26.7%
Net income growth	93.56%
Net income growth (Q)	25.33%
Net income growth (QoQ)	-4.07%
Net income growth 3Y	60.19%
Net income growth 5Y	34.49%
Net income growth quarters	11
Net income growth years	2
OCF growth	156.73%
OCF growth (Q)	246.29%
OCF growth (QoQ)	100.45%
OCF growth 10Y	23.94%
OCF growth 3Y	65.09%
OCF growth 5Y	31.67%
Operating income growth	78.34%
Operating income growth (Q)	77.42%
Operating income growth 3Y	68.37%
Operating income growth 5Y	38.93%
Revenue growth	49.58%
Revenue growth (Q)	47.67%
Revenue growth (QoQ)	16.04%
Revenue growth 10Y	14.48%
Revenue growth 3Y	39.23%
Revenue growth 5Y	24.41%
Revenue growth quarters	13
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -51.3B
Depreciation and amortization	BRL 11.2B
EBIT	BRL 205.2B
EBITDA	BRL 216.1B
EPS	BRL 5.31
Financing cash flow	BRL 13.5B
Free cash flow	BRL 94.2B
Free cash flow minus SBC	BRL 90.9B
Gross profit	BRL 344.2B
Income taxes	BRL 35.7B
Investing cash flow	BRL -130B
Net borrowing	BRL 81.4B
Net cash flow	BRL 28.9B
Net income	BRL 138.4B
Operating cash flow minus SBC	BRL 142.1B
Operating income	BRL 205.2B
Revenue	BRL 412.7B
Stock-based compensation	BRL 3.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.55
Book value per share	BRL 196.88
Debt / EBITDA	1.31
Debt / equity	1.62
Debt / FCF	3.02
Goodwill	BRL 47.4B
Interest coverage	215.26
Long-term assets	BRL 391B
Long-term liabilities	BRL 306.1B
Net cash (debt)	BRL -234B
Net cash / market cap	-3.83%
Net debt / EBITDA	1.08
Net debt / equity	1.33
Net debt / FCF	2.48
Piotroski F-Score	7
Property, plant and equipment	BRL 156.8B
Shareholders' equity	BRL 175.5B
Tangible book value	BRL 35.9B
Tangible book value per share	BRL 40.21
Total assets	BRL 737.1B
Total cash	BRL 46.4B
Total debt	BRL 284.5B
Total liabilities	BRL 561.6B
WACC	6.45%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	BRL 346.2B
Current liabilities	BRL 255.5B
Current ratio	1.35
Inventory turnover	0.95
Net working capital	BRL 77.9B
Quick ratio	0.68
Working capital	BRL 87.7B
Working capital turnover	29.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.62%
Dividend growth	15.78%
Dividend growth (10Y)	8.45%
Dividend growth (3Y)	15.54%
Dividend growth (5Y)	15.78%
Dividend growth years	6
Dividend payment date	2026-09-16
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.77
Dividend yield	0.34%
Ex-dividend date	2026-08-13
Last dividend	BRL 0.04
Payout ratio	21.66%
Shareholder yield	0.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	2,726.8%
10Y return CAGR	41.41%
10Y total return	3,095.42%
150-day SMA	BRL 189.31
1D price change	-1.11%
1M price change	10.87%
1M total return	10.87%
1W price change	9.23%
1W total return	9.23%
1Y price change	53.27%
1Y return CAGR	53.98%
1Y total return	53.93%
20-day SMA	BRL 206.68
200-day SMA	BRL 186.63
3M price change	12.85%
3M total return	12.95%
3Y price change	140.85%
3Y return CAGR	34.67%
3Y total return	144.3%
50-day SMA	BRL 203.95
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 237.71
52-week high date	2026-10-26
52-week low	BRL 142.00
52-week low date	2026-04-29
5Y price change	394.28%
5Y return CAGR	38.51%
5Y total return	409.71%
6M price change	54.18%
6M total return	54.5%
All-time high	BRL 237.71
All-time high date	2026-10-26
All-time low	BRL 2.96
All-time low date	2012-08-24
Average true range (ATR)	BRL 8.15
Average volume	55.6K
Beta (5Y)	0.45
Change from 52-week high	-4.15%
Change from 52-week low	60.45%
Change from all-time high	-4.15%
Change from all-time low	7,610.32%
Change from open	0.44%
Day's gap	-1.54%
Dollar volume	BRL 25.5M
High price	BRL 230.67
Low price	BRL 225.67
Monthly RSI	67.52
Open price	BRL 226.85
Position in 52-week range	43.4%
Previous close	BRL 230.40
Price vs 150-day SMA	20.35%
Price vs 20-day SMA	10.24%
Price vs 200-day SMA	22.08%
Price vs 50-day SMA	11.71%
Relative volume	2.01
RSI	66.03
Sharpe ratio	1.31
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	1.01
Sortino ratio	2.33
Sortino ratio (3Y)	1.33
Sortino ratio (5Y)	1.75
Volume	111.8K
Weekly RSI	65.67
YTD price change	15.48%
YTD total return	15.86%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888.9M
Shares change (QoQ)	-0.25%
Shares change (YoY)	-0.62%
Shares held by insiders	0.17%
Shares held by institutions	89.36%
Short ratio	2.8 days

Deeper analysis on BVMF/LILY34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/LILY34 report

Is a complete BVMF/LILY34 research report available?

No complete published report is available for bvmf/LILY34 (BVMF/LILY34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/LILY34 (BVMF/LILY34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/LILY34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/LILY34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/LILY34

Frequently asked questions